ヒストン修飾を標的とした卵巣明細胞癌の新規治療薬の開発Machiko Kojima(The University of Tokyo)Institutional Repositories DataBase (IRDB)March 23, 202010.15083/0002005096Cited by 0SaveCiteExport RISWatch citationsRelated PapersThe histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells|Oncology Letters|2020|31The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation|BMC Cancer|2019|17